Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
5.53
-0.13 (-2.30%)
At close: Mar 6, 2026, 4:00 PM EST
5.57
+0.04 (0.72%)
After-hours: Mar 6, 2026, 7:59 PM EST
Evolus Employees
Evolus had 334 employees as of December 31, 2025. The number of employees increased by 2 or 0.60% compared to the previous year.
Employees
334
Change (1Y)
2
Growth (1Y)
0.60%
Revenue / Employee
$889,749
Profits / Employee
-$154,614
Market Cap
359.78M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Canopy Growth | 960 |
| Emergent BioSolutions | 900 |
| Organogenesis Holdings | 854 |
| Kamada | 420 |
| Lifecore Biomedical | 406 |
| Ironwood Pharmaceuticals | 253 |
| Akebia Therapeutics | 194 |
| Aquestive Therapeutics | 142 |
EOLS News
- 4 days ago - Evolus Reports Fourth Quarter and Full-Year 2025 Financial Results; Delivers Sixth Consecutive Year of Double-Digit Growth and Expects Sustainable Profitability1 Beginning in 2026 - Business Wire
- 10 days ago - Evolus to Participate in The Leerink Partners Global Healthcare Conference - Business Wire
- 18 days ago - Evolus to Report Fourth Quarter and Full-Year 2025 Financial Results on March 3, 2026 - Business Wire
- 22 days ago - Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 2 months ago - Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2025 Net Revenue - Business Wire
- 4 months ago - Evolus Reports Third Quarter 2025 Financial Results - Business Wire
- 4 months ago - Evolus to Participate in 2025 Stifel Healthcare Conference - Business Wire
- 4 months ago - Evolus to Report Third Quarter Financial Results on November 5, 2025 - Business Wire